Madde Kullanım Bozukluklarına Sahip Kadınların Desteklenmesi ve Rehabilitasyonu
References
Rissman EF, Lynch WJ. Role of hormones in substance use disorders. Neuroendocrinology. 2023; 113(11): 1095-1098.
Maël G, Daniel O. The link between trauma and substance use disorders: a literature review. Arch Clin Psychiatry. 2022; 49(6):66-72.
Gopman S. Prenatal and postpartum care of women with substance use disorders. Obstet Gynecol Clin. 2014; 41(2): 213-228.
McHugh RK, Hearon BA, Otto MW. Cognitive behavioral therapy for substance use disorders. Psychiatr Clin. 2010; 33(3): 511-525.
Valeri L, Sugarman DE, Reilly ME, McHugh RK, Fitzmaurice GM, Greenfield SF. Group therapy for women with substance use disorders: In-session affiliation predicts women's substance use treatment outcomes. J Subst Abuse Treat. 2018; 94: 60-68.
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy. Medication-Assisted Treatment for Opioid Use Disorder: Proceedings of a Workshop—in Brief. Washington (DC): National Academies Press (US); 2018 Nov 30. Erişim adresi: https://www.ncbi.nlm.nih.gov/books/NBK534504/ doi: 10.17226/25322 Erişim tarihi:08.08.2024
Patton D. The Power, Capacity, and Resiliency of Women in Substance Use Disorder Recovery to Overcome Multiple and Complex Housing Transitions. Soc Sci. 2024; 13(4): 206. https://doi.org/10.3390/socsci13040206
Lanzillotta-Rangeley J, Leslie J, Little M, Stem J, Asselin E, Kurahovic M. Educational program to increase substance use disorder knowledge and decrease stigma in first-year nursing students. Pain Manag Nurs. 2020; 21(5): 435-440.
NIDA. What are the treatments for heroin use disorder?. 2021. Erişim adresi: https://nida.nih.gov/publications/research-reports/heroin/what-are-treatments-heroin-use-disorder Erişim tarihi:08.08.2024
Gowing L, Ali R, White JM, Mbewe D. Buprenorphine for managing opioid withdrawal. Cochrane Database of Systematic Reviews 2017, Issue 2. Art. No.: CD002025. DOI: 10.1002/14651858.CD002025.pub5
Amato L, Minozzi S, Davoli M, Vecchi S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev. 2011;(10):CD004147. Published 2011 Oct 5. doi:10.1002/14651858.CD004147.pub4
Lingford-Hughes AR, Welch S, Peters L, Nutt DJ. Evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2012; 26(7): 899-952.
Weaver MF, Hopper JA, Gunderson EW. Designer drugs 2015: assessment and management. Addict Sci Clin Pract 10, 8 (2015). https://doi.org/10.1186/s13722-015-0024-7
Sharp A, Brown B, Shreve T, Moore K, Carlson M, Braughton D. Direct-care staff perceptions of patient engagement and treatment planning in detox. J Behav Health Serv Res. 2021 Oct;48:566-82.
Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2014(2):CD002207. Published 2014 Feb 6. doi:10.1002/14651858.CD002207.pub4
Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Substance Abuse. 2007;28(3):7-30. doi:10.1300/J465v28n03_03
Renbarger KM, Shieh C, Moorman M, Latham-Mintus K, Draucker C. Health care encounters of pregnant and postpartum women with substance use disorders. West J Nurs Res. 2020; 42(8): 612-628.
Jones HE, Heil SH, Baewert A, Arria AM, Kaltenbach K, Martin PR, et al. Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction. 2012; 107 Suppl 1: 5-27. https://doi.org/10.1111/j.1360-0443.2012.04035.x
Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010; 363(24): 2320-2331.
Goler NC, Armstrong MA, Taillac CJ, Osejo VM. Substance abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard. J Perinatol. 2008; 28(9): 597-603. https://doi.org/10.1038/jp.2008.70
Heil SH, Jones HE, Arria A, Kaltenbach K, Coyle MG, Fischer G, et al. Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat. 2011; 40(2): 199-202.
Jones HE, O'Grady KE, Malfi D, Tuten M. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict. 2008; 17(5): 372-86.
Jumah NA, Graves L, Kahan M. The management of opioid dependence during pregnancy in rural and remote settings. Canadian Medical Association Journal. 2015; Jan 6;187(1):E41-E46. doi: 10.1503/cmaj.131723. Epub 2014 Oct 6. PMID: 25288311; PMCID: PMC4284191.
Hudak ML, Tan RC; The Committee on Drugs and the Committee on Fetus and Newborn. Neonatal Drug Withdrawal. Pediatrics. 2012 Feb;129(2):e540-60. doi: 10.1542/peds.2011-3212.
Jansson LM, Velez M, Harrow C. The opioid-exposed newborn: Assessment and pharmacologic management. J Opioid Manag. 2008; 4(5): 288-296.
Winklbaur B, Kopf N, Ebner N, Jung E, Thau K, Fischer G. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction. 2008; 103(9): 1429-1440.
Wampold BE. The great psychotherapy debate: Models, methods, and findings. Routledge; 2013 Aug 21.
Michie S, Johnston M, Carey R. Behavior Change Techniques. In: Gellman MD, editor. Encyclopedia of Behavioral Medicine. Springer, Cham; 2020. https://doi.org/10.1007/978-3-030-39903-0_1661
Najavits LM. Seeking Safety: A treatment manual for PTSD and substance abuse. Guilford Press; 2002.
Newman CF. Cognitive therapy of substance abuse. Guilford Press; 2001 Jan 16.
Linehan MM. Cognitive-behavioral treatment of borderline personality disorder. Guilford Press; 1993.
Rogers C. Client centered therapy. Hachette UK; 2012 Mar 1.
Yalom ID, Crouch EC. The theory and practice of group psychotherapy. Br J Psychiatry. 1990; 157(2): 304-306.
Varghese M, Kirpekar V, Loganathan S. Family Interventions: Basic Principles and Techniques. Indian J Psychiatry. 2020; 62(Suppl 2): 192-200. doi: 10.4103/psychiatry.IndianJPsychiatry_770_19. Epub 2020 Jan 17. PMID: 32055062; PMCID: PMC7001353.
West AL, Dauber S, Gagliardi L, Correll L, Lilli AC, Daniels J. Systematic review of community-and home-based interventions to support parenting and reduce risk of child maltreatment among families with substance-exposed newborns. Child Maltreat. 2020; 25(2): 137-151.
Coupland H, Moensted ML, Reid S, White B, Eastwood J, Haber P, Day C. Developing a model of care for substance use in pregnancy and parenting services, Sydney, Australia: Service provider perspectives. J Subst Abuse Treat. 2021; 131: 108420.
Gulbransen K. A novel care model: Maternity care experiences of pregnant individuals who use substances. 2023. Erişim adresi: https://mspace.lib.umanitoba.ca/items/bdf9974b-e384-4f3b-99aa-b498e551a657 Erişim tarihi:08.08.2024
Davidson L, White W. The concept of recovery as an organizing principle for integrating mental health and addiction services. J Behav Health Serv Res. 2007; 34(2): 109-120.
Szczygiel, N., Au-Yong-Oliveira, M., Coutinho, A., Rodrigues, A., & Lopes, R. (2018). Substance Use Disorders and Reintegration–A Novel Perspective on Empathy for Those in Need. Journal of Corporate Responsibility and Leadership, 5(4), 67-80.
Bjørlykhaug, K. I., Karlsson, B., Hesook, S. K., & Kleppe, L. C. (2022). Social support and recovery from mental health problems: A scoping review. Nordic social work research, 12(5), 666-697.
Magura S. The role of work in substance dependency treatment: A preliminary overview. Subst Use Misuse. 2003; 38(11-13): 1865-1876.
Magura S, Cleland C, Vogel HS, Knight EL. Effects of “dual focus” mutual aid on self-efficacy for recovery and quality of life. Adm Policy Ment Health. 2007; 34(1): 1-12.
Baldwin SA, Murray DM, Shadish WR. Empirically supported treatments or type I errors? Problems with the analysis of data from group-administered treatments. J Consult Clin Psychol. 2005; 73(5): 924.
Tsemberis S, Gulcur L, Nakae M. Housing first, consumer choice, and harm reduction for homeless individuals with a dual diagnosis. Am J Public Health. 2004; 94(4): 651-656.
Botvin GJ, Griffin KW. School-based programmes to prevent alcohol, tobacco and other drug use. Int Rev Psychiatry. 2007; 19(6): 607-615.
Corrigan PW, Kuwabara SA, O'Shaughnessy J. The public stigma of mental illness and drug addiction: Findings from a stratified random sample. J Soc Work. 2009; 9(2): 139-147.
McGinty K, McCammon SL, Koeppen VP. The complexities of implementing a wraparound approach to service provision: A view from the field. J Fam Soc Work. 2001; 5(3): 95-110.
National Research Council (US) Committee on Substance Abuse Prevention Research, Gerstein DR, Green LW, editors. Preventing Drug Abuse: What do we know?. Washington (DC): National Academies Press (US); 1993.
Hornik R. Public health communication: Evidence for behavior change. Routledge; 2002. https://doi.org/10.4324/9781410603029
Kumpfer KL, Magalhães C, Xie J. Cultural adaptations of evidence-based family interventions to strengthen families and improve children's developmental outcomes. Eur J Dev Psychol. 2010; 7(1): 108-119.
Metz V, Köchl B, Fischer G. Should pregnant women with substance use disorders be managed differently? Neuropsychiatry (London). 2012; 2(1): 29-41. doi: 10.2217/npy.11.74. PMID: 23243466; PMCID: PMC3521595.
Fretts RC. Etiology and prevention of stillbirth. Am J Obstet Gynecol. 2005; 193(6): 1923-1935. https://doi.org/10.1016/j.ajog.2005.03.074
Bibring GL, Dwyer TF, Huntington DS, Valenstein AF. A study of the psychological processes in pregnancy and of the earliest mother-child relationship: II. Methodological considerations. Psychoanal Study Child. 1961; 16(1): 25-44.
Enkin M, et al. A guide to effective care in pregnancy and childbirth. Oxford: Oxford University Press; 2000.
Declercq ER, Sakala C, Corry MP, Applebaum S. Listening to Mothers II: Report of the Second National U.S. Survey of Women's Childbearing Experiences: Conducted January-February 2006 for Childbirth Connection by Harris Interactive(R) in partnership with Lamaze International. J Perinat Educ. 2007; 16(4): 9-14. doi: 10.1624/105812407X244769. PMID: 18769512; PMCID: PMC2174380.
National Partnership for Women & Families. Continuous Support for Women During Childbirth: 2017 Cochrane Review Update Key Takeaways. J Perinat Educ. 2018 Oct;27(4):193-197. doi: 10.1891/1058-1243.27.4.193. PMID: 31073265; PMCID: PMC6491161.
American College of Obstetricians and Gynecologists. Opioid use and opioid use disorder in pregnancy. Committee Opinion No. 711. Obstet Gynecol 2017;130:e81–94.
Kroelinger CD, Rice ME, Okoroh EM, DeSisto CL, Barfield WD. Seven years later: state neonatal risk-appropriate care policy consistency with the 2012 American Academy of Pediatrics Policy. J Perinatol. 2022; 42(5): 595-602.
Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol. 2005; 106(5 Pt 1): 1071-1083. https://doi.org/10.1097/01.AOG.0000183597.31630.db
Shelton D, Ramage M, Hughes P, Tak C. Factors associated with contraceptive use among postpartum women with substance use disorder. Sex Reprod Healthc. 2022; 33: 100764.
Dennis M, Scott CK. Managing addiction as a chronic condition. Addict Sci Clin Pract. 2007; 4(1): 45-55. doi: 10.1151/ascp074145. PMID: 18292710; PMCID: PMC2797101
McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. Reconsidering the evaluation of addiction treatment: from retrospective follow‐up to concurrent recovery monitoring. Addiction. 2005; 100(4): 447-458.
Moos RH, Moos BS. Rates and predictors of relapse after natural and treated remission from alcohol use disorders. Addiction. 2006; 101(2): 212-222.
McKay JR. Continuing care research: What we have learned and where we are going. J Subst Abuse Treat. 2009;36(2):131-45.
Simakhodskaya Z, Haddad F, Quintero M, Malavade K. Innovative Use of Crisis Intervention Services with Psychiatric Emergency Room Patients. Prim Psychiatry. 2009; 16(9), 60-65.
Marsch LA, Carroll KM, Kiluk BD. Technology-based interventions for the treatment and recovery management of substance use disorders: A JSAT special issue. J Subst Abuse Treat. 2014; 46(1): 1-4.
Humphreys K, Tucker J. Toward more responsive and effective intervention systems for alcohol-related problems. Addiction. 2002; 97(2): 126-132.
Maël G, Daniel O. The link between trauma and substance use disorders: a literature review. Arch Clin Psychiatry. 2022; 49(6):66-72.
Gopman S. Prenatal and postpartum care of women with substance use disorders. Obstet Gynecol Clin. 2014; 41(2): 213-228.
McHugh RK, Hearon BA, Otto MW. Cognitive behavioral therapy for substance use disorders. Psychiatr Clin. 2010; 33(3): 511-525.
Valeri L, Sugarman DE, Reilly ME, McHugh RK, Fitzmaurice GM, Greenfield SF. Group therapy for women with substance use disorders: In-session affiliation predicts women's substance use treatment outcomes. J Subst Abuse Treat. 2018; 94: 60-68.
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy. Medication-Assisted Treatment for Opioid Use Disorder: Proceedings of a Workshop—in Brief. Washington (DC): National Academies Press (US); 2018 Nov 30. Erişim adresi: https://www.ncbi.nlm.nih.gov/books/NBK534504/ doi: 10.17226/25322 Erişim tarihi:08.08.2024
Patton D. The Power, Capacity, and Resiliency of Women in Substance Use Disorder Recovery to Overcome Multiple and Complex Housing Transitions. Soc Sci. 2024; 13(4): 206. https://doi.org/10.3390/socsci13040206
Lanzillotta-Rangeley J, Leslie J, Little M, Stem J, Asselin E, Kurahovic M. Educational program to increase substance use disorder knowledge and decrease stigma in first-year nursing students. Pain Manag Nurs. 2020; 21(5): 435-440.
NIDA. What are the treatments for heroin use disorder?. 2021. Erişim adresi: https://nida.nih.gov/publications/research-reports/heroin/what-are-treatments-heroin-use-disorder Erişim tarihi:08.08.2024
Gowing L, Ali R, White JM, Mbewe D. Buprenorphine for managing opioid withdrawal. Cochrane Database of Systematic Reviews 2017, Issue 2. Art. No.: CD002025. DOI: 10.1002/14651858.CD002025.pub5
Amato L, Minozzi S, Davoli M, Vecchi S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev. 2011;(10):CD004147. Published 2011 Oct 5. doi:10.1002/14651858.CD004147.pub4
Lingford-Hughes AR, Welch S, Peters L, Nutt DJ. Evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2012; 26(7): 899-952.
Weaver MF, Hopper JA, Gunderson EW. Designer drugs 2015: assessment and management. Addict Sci Clin Pract 10, 8 (2015). https://doi.org/10.1186/s13722-015-0024-7
Sharp A, Brown B, Shreve T, Moore K, Carlson M, Braughton D. Direct-care staff perceptions of patient engagement and treatment planning in detox. J Behav Health Serv Res. 2021 Oct;48:566-82.
Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2014(2):CD002207. Published 2014 Feb 6. doi:10.1002/14651858.CD002207.pub4
Babor TF, McRee BG, Kassebaum PA, Grimaldi PL, Ahmed K, Bray J. Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse. Substance Abuse. 2007;28(3):7-30. doi:10.1300/J465v28n03_03
Renbarger KM, Shieh C, Moorman M, Latham-Mintus K, Draucker C. Health care encounters of pregnant and postpartum women with substance use disorders. West J Nurs Res. 2020; 42(8): 612-628.
Jones HE, Heil SH, Baewert A, Arria AM, Kaltenbach K, Martin PR, et al. Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review. Addiction. 2012; 107 Suppl 1: 5-27. https://doi.org/10.1111/j.1360-0443.2012.04035.x
Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010; 363(24): 2320-2331.
Goler NC, Armstrong MA, Taillac CJ, Osejo VM. Substance abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard. J Perinatol. 2008; 28(9): 597-603. https://doi.org/10.1038/jp.2008.70
Heil SH, Jones HE, Arria A, Kaltenbach K, Coyle MG, Fischer G, et al. Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat. 2011; 40(2): 199-202.
Jones HE, O'Grady KE, Malfi D, Tuten M. Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. Am J Addict. 2008; 17(5): 372-86.
Jumah NA, Graves L, Kahan M. The management of opioid dependence during pregnancy in rural and remote settings. Canadian Medical Association Journal. 2015; Jan 6;187(1):E41-E46. doi: 10.1503/cmaj.131723. Epub 2014 Oct 6. PMID: 25288311; PMCID: PMC4284191.
Hudak ML, Tan RC; The Committee on Drugs and the Committee on Fetus and Newborn. Neonatal Drug Withdrawal. Pediatrics. 2012 Feb;129(2):e540-60. doi: 10.1542/peds.2011-3212.
Jansson LM, Velez M, Harrow C. The opioid-exposed newborn: Assessment and pharmacologic management. J Opioid Manag. 2008; 4(5): 288-296.
Winklbaur B, Kopf N, Ebner N, Jung E, Thau K, Fischer G. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction. 2008; 103(9): 1429-1440.
Wampold BE. The great psychotherapy debate: Models, methods, and findings. Routledge; 2013 Aug 21.
Michie S, Johnston M, Carey R. Behavior Change Techniques. In: Gellman MD, editor. Encyclopedia of Behavioral Medicine. Springer, Cham; 2020. https://doi.org/10.1007/978-3-030-39903-0_1661
Najavits LM. Seeking Safety: A treatment manual for PTSD and substance abuse. Guilford Press; 2002.
Newman CF. Cognitive therapy of substance abuse. Guilford Press; 2001 Jan 16.
Linehan MM. Cognitive-behavioral treatment of borderline personality disorder. Guilford Press; 1993.
Rogers C. Client centered therapy. Hachette UK; 2012 Mar 1.
Yalom ID, Crouch EC. The theory and practice of group psychotherapy. Br J Psychiatry. 1990; 157(2): 304-306.
Varghese M, Kirpekar V, Loganathan S. Family Interventions: Basic Principles and Techniques. Indian J Psychiatry. 2020; 62(Suppl 2): 192-200. doi: 10.4103/psychiatry.IndianJPsychiatry_770_19. Epub 2020 Jan 17. PMID: 32055062; PMCID: PMC7001353.
West AL, Dauber S, Gagliardi L, Correll L, Lilli AC, Daniels J. Systematic review of community-and home-based interventions to support parenting and reduce risk of child maltreatment among families with substance-exposed newborns. Child Maltreat. 2020; 25(2): 137-151.
Coupland H, Moensted ML, Reid S, White B, Eastwood J, Haber P, Day C. Developing a model of care for substance use in pregnancy and parenting services, Sydney, Australia: Service provider perspectives. J Subst Abuse Treat. 2021; 131: 108420.
Gulbransen K. A novel care model: Maternity care experiences of pregnant individuals who use substances. 2023. Erişim adresi: https://mspace.lib.umanitoba.ca/items/bdf9974b-e384-4f3b-99aa-b498e551a657 Erişim tarihi:08.08.2024
Davidson L, White W. The concept of recovery as an organizing principle for integrating mental health and addiction services. J Behav Health Serv Res. 2007; 34(2): 109-120.
Szczygiel, N., Au-Yong-Oliveira, M., Coutinho, A., Rodrigues, A., & Lopes, R. (2018). Substance Use Disorders and Reintegration–A Novel Perspective on Empathy for Those in Need. Journal of Corporate Responsibility and Leadership, 5(4), 67-80.
Bjørlykhaug, K. I., Karlsson, B., Hesook, S. K., & Kleppe, L. C. (2022). Social support and recovery from mental health problems: A scoping review. Nordic social work research, 12(5), 666-697.
Magura S. The role of work in substance dependency treatment: A preliminary overview. Subst Use Misuse. 2003; 38(11-13): 1865-1876.
Magura S, Cleland C, Vogel HS, Knight EL. Effects of “dual focus” mutual aid on self-efficacy for recovery and quality of life. Adm Policy Ment Health. 2007; 34(1): 1-12.
Baldwin SA, Murray DM, Shadish WR. Empirically supported treatments or type I errors? Problems with the analysis of data from group-administered treatments. J Consult Clin Psychol. 2005; 73(5): 924.
Tsemberis S, Gulcur L, Nakae M. Housing first, consumer choice, and harm reduction for homeless individuals with a dual diagnosis. Am J Public Health. 2004; 94(4): 651-656.
Botvin GJ, Griffin KW. School-based programmes to prevent alcohol, tobacco and other drug use. Int Rev Psychiatry. 2007; 19(6): 607-615.
Corrigan PW, Kuwabara SA, O'Shaughnessy J. The public stigma of mental illness and drug addiction: Findings from a stratified random sample. J Soc Work. 2009; 9(2): 139-147.
McGinty K, McCammon SL, Koeppen VP. The complexities of implementing a wraparound approach to service provision: A view from the field. J Fam Soc Work. 2001; 5(3): 95-110.
National Research Council (US) Committee on Substance Abuse Prevention Research, Gerstein DR, Green LW, editors. Preventing Drug Abuse: What do we know?. Washington (DC): National Academies Press (US); 1993.
Hornik R. Public health communication: Evidence for behavior change. Routledge; 2002. https://doi.org/10.4324/9781410603029
Kumpfer KL, Magalhães C, Xie J. Cultural adaptations of evidence-based family interventions to strengthen families and improve children's developmental outcomes. Eur J Dev Psychol. 2010; 7(1): 108-119.
Metz V, Köchl B, Fischer G. Should pregnant women with substance use disorders be managed differently? Neuropsychiatry (London). 2012; 2(1): 29-41. doi: 10.2217/npy.11.74. PMID: 23243466; PMCID: PMC3521595.
Fretts RC. Etiology and prevention of stillbirth. Am J Obstet Gynecol. 2005; 193(6): 1923-1935. https://doi.org/10.1016/j.ajog.2005.03.074
Bibring GL, Dwyer TF, Huntington DS, Valenstein AF. A study of the psychological processes in pregnancy and of the earliest mother-child relationship: II. Methodological considerations. Psychoanal Study Child. 1961; 16(1): 25-44.
Enkin M, et al. A guide to effective care in pregnancy and childbirth. Oxford: Oxford University Press; 2000.
Declercq ER, Sakala C, Corry MP, Applebaum S. Listening to Mothers II: Report of the Second National U.S. Survey of Women's Childbearing Experiences: Conducted January-February 2006 for Childbirth Connection by Harris Interactive(R) in partnership with Lamaze International. J Perinat Educ. 2007; 16(4): 9-14. doi: 10.1624/105812407X244769. PMID: 18769512; PMCID: PMC2174380.
National Partnership for Women & Families. Continuous Support for Women During Childbirth: 2017 Cochrane Review Update Key Takeaways. J Perinat Educ. 2018 Oct;27(4):193-197. doi: 10.1891/1058-1243.27.4.193. PMID: 31073265; PMCID: PMC6491161.
American College of Obstetricians and Gynecologists. Opioid use and opioid use disorder in pregnancy. Committee Opinion No. 711. Obstet Gynecol 2017;130:e81–94.
Kroelinger CD, Rice ME, Okoroh EM, DeSisto CL, Barfield WD. Seven years later: state neonatal risk-appropriate care policy consistency with the 2012 American Academy of Pediatrics Policy. J Perinatol. 2022; 42(5): 595-602.
Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol. 2005; 106(5 Pt 1): 1071-1083. https://doi.org/10.1097/01.AOG.0000183597.31630.db
Shelton D, Ramage M, Hughes P, Tak C. Factors associated with contraceptive use among postpartum women with substance use disorder. Sex Reprod Healthc. 2022; 33: 100764.
Dennis M, Scott CK. Managing addiction as a chronic condition. Addict Sci Clin Pract. 2007; 4(1): 45-55. doi: 10.1151/ascp074145. PMID: 18292710; PMCID: PMC2797101
McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. Reconsidering the evaluation of addiction treatment: from retrospective follow‐up to concurrent recovery monitoring. Addiction. 2005; 100(4): 447-458.
Moos RH, Moos BS. Rates and predictors of relapse after natural and treated remission from alcohol use disorders. Addiction. 2006; 101(2): 212-222.
McKay JR. Continuing care research: What we have learned and where we are going. J Subst Abuse Treat. 2009;36(2):131-45.
Simakhodskaya Z, Haddad F, Quintero M, Malavade K. Innovative Use of Crisis Intervention Services with Psychiatric Emergency Room Patients. Prim Psychiatry. 2009; 16(9), 60-65.
Marsch LA, Carroll KM, Kiluk BD. Technology-based interventions for the treatment and recovery management of substance use disorders: A JSAT special issue. J Subst Abuse Treat. 2014; 46(1): 1-4.
Humphreys K, Tucker J. Toward more responsive and effective intervention systems for alcohol-related problems. Addiction. 2002; 97(2): 126-132.
Pages
319-342
Published
January 22, 2025
Copyright (c) 2025 Academician Publishing Book Portal
